Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Bhide

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Bioorganic & Medicinal Chemistry Letters|April 9, 2008
Discovery and preclinical studies of 5-isopropyl-6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-(2-methyl-1H-pyrrolo[2,3-b]pyridin-5-yl)pyrrolo[2,1-f][1,2,4]triazin-4-amine (BMS-645737), an in vivo active potent VEGFR-2 inhibitorRéjean Ruel, Carl Thibeault, Alexandre L'Heureux, et al.
Journal of Medicinal Chemistry|February 22, 2008
Discovery of brivanib alaninate ((S)-((R)-1-(4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy)propan-2-yl)2-aminopropanoate), a novel prodrug of dual vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1 kinase inhibitor (BMS-540215)Zhen-wei Cai, Yongzheng Zhang, Robert M Borzilleri, et al.
Journal of Medicinal Chemistry|January 5, 1996
Development of highly potent inhibitors of Ras farnesyltransferase possessing cellular and in vivo activityK Leftheris, T Kline, G D Vite, et al.
Bioorganic & Medicinal Chemistry Letters|January 22, 2017
Discovery of 7-(3-(piperazin-1-yl)phenyl)pyrrolo[2,1-f][1,2,4]triazin-4-amine derivatives as highly potent and selective PI3Kδ inhibitorsLan-Ying Qin, Zheming Ruan, Robert J Cherney, et al.
Journal of Medicinal Chemistry|March 31, 2006
Discovery and preclinical studies of (R)-1-(4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5- methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy)propan- 2-ol (BMS-540215), an in vivo active potent VEGFR-2 inhibitorRajeev S Bhide, Zhen-Wei Cai, Yong-Zheng Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|May 30, 2006
Synthesis and SAR of pyrrolotriazine-4-one based Eg5 inhibitorsKyoung Soon Kim, Songfeng Lu, Lyndon A Cornelius, et al.
The Plant Cell|August 29, 2013
The Tarenaya hassleriana genome provides insight into reproductive trait and genome evolution of crucifersShifeng Cheng, Erik van den Bergh, Peng Zeng, et al.
ACS Medicinal Chemistry Letters|July 18, 2020
Optimization of Nicotinamides as Potent and Selective IRAK4 Inhibitors with Efficacy in a Murine Model of PsoriasisSatheesh Nair, Sreekantha Ratna Kumar, Venkatram Reddy Paidi, et al.
Journal of Medicinal Chemistry|May 26, 2017
Identification of a Potent, Selective, and Efficacious Phosphatidylinositol 3-Kinase δ (PI3Kδ) Inhibitor for the Treatment of Immunological DisordersQingjie Liu, Qing Shi, David Marcoux, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Bioorganic & Medicinal Chemistry Letters|April 9, 2008
Discovery and preclinical studies of 5-isopropyl-6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-(2-methyl-1H-pyrrolo[2,3-b]pyridin-5-yl)pyrrolo[2,1-f][1,2,4]triazin-4-amine (BMS-645737), an in vivo active potent VEGFR-2 inhibitorRéjean Ruel, Carl Thibeault, Alexandre L'Heureux, et al.
Journal of Medicinal Chemistry|February 22, 2008
Discovery of brivanib alaninate ((S)-((R)-1-(4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy)propan-2-yl)2-aminopropanoate), a novel prodrug of dual vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1 kinase inhibitor (BMS-540215)Zhen-wei Cai, Yongzheng Zhang, Robert M Borzilleri, et al.
Journal of Medicinal Chemistry|January 5, 1996
Development of highly potent inhibitors of Ras farnesyltransferase possessing cellular and in vivo activityK Leftheris, T Kline, G D Vite, et al.
Bioorganic & Medicinal Chemistry Letters|January 22, 2017
Discovery of 7-(3-(piperazin-1-yl)phenyl)pyrrolo[2,1-f][1,2,4]triazin-4-amine derivatives as highly potent and selective PI3Kδ inhibitorsLan-Ying Qin, Zheming Ruan, Robert J Cherney, et al.
Journal of Medicinal Chemistry|March 31, 2006
Discovery and preclinical studies of (R)-1-(4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5- methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy)propan- 2-ol (BMS-540215), an in vivo active potent VEGFR-2 inhibitorRajeev S Bhide, Zhen-Wei Cai, Yong-Zheng Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|May 30, 2006
Synthesis and SAR of pyrrolotriazine-4-one based Eg5 inhibitorsKyoung Soon Kim, Songfeng Lu, Lyndon A Cornelius, et al.
The Plant Cell|August 29, 2013
The Tarenaya hassleriana genome provides insight into reproductive trait and genome evolution of crucifersShifeng Cheng, Erik van den Bergh, Peng Zeng, et al.
ACS Medicinal Chemistry Letters|July 18, 2020
Optimization of Nicotinamides as Potent and Selective IRAK4 Inhibitors with Efficacy in a Murine Model of PsoriasisSatheesh Nair, Sreekantha Ratna Kumar, Venkatram Reddy Paidi, et al.
Journal of Medicinal Chemistry|May 26, 2017
Identification of a Potent, Selective, and Efficacious Phosphatidylinositol 3-Kinase δ (PI3Kδ) Inhibitor for the Treatment of Immunological DisordersQingjie Liu, Qing Shi, David Marcoux, et al.
Pageof 5